Odisha-based Serendipity Space secured pre-seed funding from Campus Fund to advance space-based pharmaceutical manufacturing. The company aims to leverage microgravity for high-quality drug crystallization via its ‘Alchemy’ platform. Validated modules demonstrate lab-grade results, potentially yielding $1.2B NPV per drug and tapping into a projected $10B+ in-space manufacturing market by 2030. Funding will support technical demonstrations.

Research identifies cytidine diphosphate diacylglycerol synthase 2 (CDS2) as a synthetic lethal target, particularly in mesenchymal-like cancers. Blocking CDS2 proves vulnerable when CDS1 is also inhibited, offering a potential therapeutic strategy. Studies reveal a critical aspartic acid residue in CDS2’s catalytic activity, highlighting its role in cancer cell survival.

Single-cell long-read Hi-C (scNanoHi-C2) reveals 3D genome reorganization in developing germ cells. The study details hierarchical chromatin structures across embryonic stages, identifying synergies and recombination hotspots, and mapping cell cycle-dependent organization in male germ cells.

Quantum-Si’s Next-Gen Protein Sequencing (NGPS) with protein barcoding accelerates mRNA-LNP screening. This method enables multiplexed, high-throughput analysis of delivery & protein expression *in vitro* & *in vivo*, surpassing traditional methods. Barcodes linked to mRNA allow for direct protein-level readout, identifying optimal candidates for targeted therapies beyond the liver. The technology offers efficient screening & improved candidate selection for mRNA therapeutics.

ReSURF is a stretchable, self-healing sensor for real-time water quality monitoring. It detects contaminants like oils & fluorinated compounds in milliseconds without external power. The recyclable material generates electrical signals upon contact with pollutants, enabling sustainable on-site surveillance.

A British lab developed CL1, a “flesh computer” hybrid of 800,000 human neurons & silicon chips. It consumes minimal energy (1,000 watts/rack) & outperforms machine learning in some tasks. Units ship soon for $35k or rent for $300/week; neurons survive 6 months. Potential uses include drug testing & brain research.

Scientists re-analyzed Kepler data & confirmed two planets (KOI-134 b & c) orbit a star in a unique system. The planets have tilted orbits & interact gravitationally, causing transit timing variations. This is the first confirmed compact, multiplanetary system with these characteristics—a “planetary carousel.”

The cell & gene therapy market is projected for significant growth, reaching $49.26B by 2034 with an 11.47% CAGR. Key drivers include rising chronic diseases & technological advancements. North America leads, with increasing investment in R&D & manufacturing. Key players focus on innovation in areas like viral vectors & personalized medicine.

Israeli drone maker Xtend opened a 10,000 sq. ft. final assembly plant in Tampa, Florida, aiming for 3,000 drone systems delivered monthly. The company plans to move production of sensors, motors, and communications systems to the U.S. as well.

BBVA will roll out Google’s GenAI tools to over 100,000 employees via Google Cloud & Workspace with Gemini. Employees report saving ~3 hours/week automating tasks. Access requires completion of internal AI training, aligning with BBVA’s governance standards. They previously deployed 11,000 ChatGPT licenses.